Keywords
HOXA6
Expression level
Clinical features
Influencing factors
Submitted : 2024-08-26
Accepted : 2024-09-10
Published : 2024-09-25
Abstract
Objective: To study and analyze the expression level of homeobox A6 (HOXA6) in patients with liver cancer and its correlation with prognosis. Methods: From January 2020 to July 2021, 43 patients with liver cancer who underwent surgery without prior radiotherapy or chemotherapy were selected. Liver cancer tissues and adjacent tissues were collected, and the expression levels of HOXA6 mRNA and protein were measured using RT-qPCR and Western blot. The expression level of HOXA6 in tumor tissues (without radiotherapy and chemotherapy) was compared with that in adjacent tissues. Additionally, the prognosis and clinical characteristics of patients with low HOXA6 expression were compared to those with high HOXA6 expression, and the factors influencing high HOXA6 expression in liver cancer patients were analyzed. Results: HOXA6 mRNA and protein expression levels in tumor tissues were significantly higher than in adjacent tissues (P < 0.05). There was no significant difference in the 1-year and 2-year survival rates between the high HOXA6 expression group and the low HOXA6 expression group (P > 0.05). However, the 3-year survival rate was lower in the high HOXA6 expression group compared to the low HOXA6 expression group (P < 0.05). There were no statistically significant differences between the two groups in terms of gender, age, tumor diameter, alpha-fetoprotein levels, or hepatitis B virus DNA levels (P > 0.05). However, significant differences were found in the number of tumor lesions, degree of differentiation, and the proportion of tumor metastasis between the two groups (P < 0.05). Multivariate logistic regression analysis revealed that the number of tumor lesions, degree of differentiation, and tumor metastasis were influencing factors for high HOXA6 expression in liver cancer patients (P < 0.05). Conclusion: HOXA6 expression levels are abnormally elevated in liver cancer patients, and higher HOXA6 expression is associated with a worse 3-year survival rate. The factors influencing HOXA6 expression include the number of tumor lesions, degree of differentiation, and tumor metastasis.
References
Mallo M, 2018, Reassessing the Role of Hox Genes during Vertebrate Development and Evolution. Trends Genet, 34(3): 209–217. https://doi.org/10.1016/j.tig.2017.11.007
Labade AS, Salvi A, Kar S, et al., 2021, Nup93 and CTCF Modulate Spatiotemporal Dynamics and Function of the HOXA Gene Locus During Differentiation. J Cell Sci, 134(23): jcs259307. https://doi.org/10.1242/jcs.259307
Guo YB, Shao YM, Chen J, et al., 2016, Effect of Overexpression of HOX Genes on Its Invasive Tendency in Cerebral Glioma. Oncol Lett, 11(1): 75–80. https://doi.org/10.3892/ol.2015.3893
Chen D, Wu Y, Jiang F, et al., 2019, Expression of HOXA Terminal Transcribed Antisense RNA in Hepatocellular Carcinoma Tissues and Its Effect on Proliferation, Invasion, and Migration of Hepatocellular Carcinoma HepG2 Cells. Cancer Research and Clinic, 31(9): 581–585.
Expert Committee for the Compilation of Norms for Diagnosis and Treatment of Primary Liver Cancer (Annual Edition), 2019, Standard for Diagnosis and Treatment of Primary Liver Cancer (2019 Edition). Chinese Journal of Clinical Medicine, 27(1): 140–156.
Chen Z, Xie H, Hu M, et al., 2020, Recent Progress in Treatment of Hepatocellular Carcinoma. Am J Cancer Res, 10(9): 2993–3036.
Abuhantash M, Collins EM, Thompson A, 2021, Role of the HOXA Cluster in HSC Emergence and Blood Cancer. Biochem Soc Trans, 49(4): 1817–1827. https://doi.org/10.1042/BST20210234
Goncalves CS, Le Boiteux E, Arnaud P, et al., 2020, HOX Gene Cluster (De)Regulation in Brain: From Neurodevelopment to Malignant Glial Tumours. Cell Mol Life Sci, 77(19): 3797–3821. https://doi.org/10.1007/s00018-020-03508-9
Khawar MB, Hamid SE, Jan T, et al., 2022, Diagnostic, Prognostic and Therapeutic Potential of Long Noncoding RNAs in Cancer. Mol Biol Rep, 49(3): 2311–2319. https://doi.org/10.1007/s11033-022-07180-z
Galani V, Lampri E, Varouktsi A, et al., 2017, Genetic and Epigenetic Alterations in Meningiomas. Clin Neurol Neurosurg, 158: 119–125. https://doi.org/10.1016/j.clineuro.2017.05.002
Li J, Ye M, Zhou C, 2020, Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer. Front Oncol, 10: 368. https://doi.org/10.3389/fonc.2020.00368
Cui Y, Yan M, Zhang C, et al., 2020, Comprehensive Analysis of the HOXA Gene Family Identifies HOXA13 as A Novel Oncogenic Gene in Kidney Renal Clear Cell Carcinoma. J Cancer Res Clin Oncol, 146(8): 1993–2006. https://doi.org/10.1007/s00432-020-03259-x
Wu S, Wu F, Jiang Z, 2018, Effect of HOXA6 on the Proliferation, Apoptosis, Migration and Invasion of Colorectal Cancer Cells. Int J Oncol, 52(6): 2093–2100. https://doi.org/10.3892/ijo.2018.4352
Zhao R, Wang Y, Zou L, et al., 2020, Hox Genes Reveal Variations in the Genomic DNA of Allotetraploid Hybrids Derived from Carassius auratus red var. (female) × Cyprinus carpio L. (male). BMC Genet, 21(1): 24. https://doi.org/10.1186/s12863-020-0823-z
Hulbert A, Jusue-Torres I, Stark A, et al., 2017, Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum. Clin Cancer Res, 23(8): 1998–2005. https://doi.org/10.1158/1078-0432.CCR-16-1371